MedPhab launches open call to support photonic medical device innovation
Europe’s first pilot line for photonics-based medical devices supports companies in the development of new medical diagnostics solutions.
MedPhab offers modular technology blocks including photonics technologies, non-photonic peripherals, system integration and post-processing steps. This modular concept enables a structured approach to highly fragmented heterogeneous photonic and non-photonic technologies such as microfluidics or surface functionalization from early phase proof-of-concept to regulated pilot production. The photonics technologies offering within MedPhab comprises fiber optics, photonic reader modules, photonic integrated circuits, micro-optics and active components provided by parties with ISO13485 certificate.
The technology offered by MedPhab can help companies to develop diagnostic solutions for hospital use to enable real-time information and monitoring of the treatment progression; novel home care services, and equipment for molecular diagnostics based on serum, saliva or urine samples.
The MedPhab Open Call provides financial support for pioneer business cases. European-based SMEs may receive a subsidy of 75 % of their innovation project, whereas large-scale European companies receive a 50% subsidy. The first cut-off date for expressing your interest is July 15th, 2021.
MedPhab has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 871345. To learn more about MedPhab and the Open Call, visit www.medphab.eu / www.photonics21.org
